Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Dana-Farber Cancer Institute
Biotech
Sanofi-backed biotech hauls in $70M series A for covalent bonds
Sanofi-backed Matchpoint is launching with $70 million in series A funds to finance its covalent chemistry-focused platform.
Max Bayer
Oct 14, 2022 6:30am
VBL lays off 35% of staff after failure-induced stock shock
Aug 2, 2022 11:03am
FDA shores up executive team with 2 hires—Chutes & Ladders
Jul 1, 2022 9:30am
Novel cancer vaccines look beyond T cells to better fight tumors
May 27, 2022 2:00pm
Alchemab CEO resigns citing 'personal reasons'—Chutes & Ladders
May 27, 2022 9:30am
Signet Therapeutics gets a $10M top-up for next-gen cancer bets
Oct 29, 2021 8:50am
